Medicine recalls
|
| |
| Canada: All lots of JAMP-Mycophenolate 250 mg capsules recalled due to possible incorrect dose, which may pose health risks |
| |
Health Canada announces that JAMP Pharma Corporation is recalling all lots of JAMP-Mycophenolate 250 mg capsules (lot number: EG22MPM001, EG22PMP002, EG22MPM003, EG23MPM001, EG23MPM002, EG23MPM003) as some capsules may weigh less or more than they should.
Patients taking an overweight or underweight capsule could unexpectedly receive a higher or lower dose than intended. Mycophenolate is a drug where differences in dose can lead to very serious side effects; therefore, it is essential that patients taking an affected product return it to the pharmacy as soon as possible for replacement.
Taking a lower dose of mycophenolate could reduce its effectiveness and lead to organ rejection, which is serious. This risk is especially high in the first weeks after transplantation. General signs and symptoms of organ rejection may include pain at the site of the transplant, feeling unwell, feeling tired or having no energy, flu-like symptoms, fever, sudden weight changes, swelling, change in heart rate or urinating less often.
Taking a higher dose than intended can increase the risk of side effects, including new or worsening nausea, vomiting, and/or diarrhea. In some cases, it may lead to over-suppression of the immune system and increased risk of infections. Infections in immunosuppressed patients can be fatal.
Please refer to the following website in Health Canada for details:
http://recalls-rappels.canada.ca/en/alert-recall/all-lots-jamp-mycophenolate-250-mg-capsules-recalled-due-possible-incorrect-dose-which
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/Monday, Aug 19, 2024
Issued at HKT 15:00
|
| |
